Cytokinetics CYTK Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $122.52M+29.2% | $94.86M-16.1% | $113.02M+72.3% | $65.58M-41.8% | ||
| $759.7M-22.6% | $981.16M+95.5% | $501.8M-30.0% | $717M+99.7% | ||
| $17.76M+6.7% | $16.65M+1,198% | $1.28M+773% | $147K-99.7% | ||
| —— | —— | —— | —— | ||
| $16.99M+11.2% | $15.28M+27.9% | $11.94M-4.2% | $12.46M+2.0% | ||
| $916.98M-17.2% | $1.11B+76.4% | $628.05M-21.0% | $795.19M+48.4% | ||
| $79.19M+20.3% | $65.82M-4.3% | $68.75M-14.5% | $80.45M+9.8% | ||
| $75.98M+1.1% | $75.16M-4.8% | $78.99M-4.5% | $82.74M+13.1% | ||
| $17.34M+125% | $7.71M-3.6% | $8M-17.5% | $9.69M+34.8% | ||
| $335.05M+131% | $145.06M+258% | $40.53M-13.2% | $46.71M-69.3% | ||
| $1.42B+1.6% | $1.4B+70.0% | $824.32M-18.8% | $1.01B+20.6% | ||
| $22.34M+9.7% | $20.37M-5.3% | $21.51M-16.0% | $25.61M+21.5% | ||
| $3.83M-60.9% | $9.81M-7.1% | $10.56M+840% | $1.12M-27.1% | ||
| $1.61M-96.9% | $52.37M— | $0— | $0-100% | ||
| $41.18M+257% | $11.52M+14.3% | $10.08M+952% | $958K— | ||
| $19.11M+0.7% | $18.98M+6.1% | $17.89M+39.5% | $12.83M-13.7% | ||
| $202.45M+12.7% | $179.67M+75.0% | $102.68M+21.3% | $84.62M+17.8% | ||
| $246.38M+164% | $93.23M+59.7% | $58.38M-8.5% | $63.81M+34.7% | ||
| $107.97M-4.1% | $112.58M-6.5% | $120.43M-5.1% | $126.9M+13.1% | ||
| —— | $0-100% | $186K-82.2% | $1.04M-76.6% | ||
| $2.08B+35.6% | $1.54B+27.0% | $1.21B+7.8% | $1.12B+87.9% | ||
| $0— | $0— | $0— | $0— | ||
| $123K+4.2% | $118K+15.7% | $102K+8.5% | $94K+11.9% | ||
| $2.83B+10.2% | $2.56B+48.6% | $1.73B+16.5% | $1.48B+2.0% | ||
| -$3.49B-29.1% | -$2.7B-27.9% | -$2.11B-33.2% | -$1.59B-31.3% | ||
| $630K-73.7% | $2.4M+24,080% | -$10K+99.7% | -$3.59M-313% | ||
| -$659.63M-387% | -$135.37M+65.0% | -$386.32M-258% | -$107.9M-144% | ||
| $1.42B+1.6% | $1.4B+70.0% | $824.32M-18.8% | $1.01B+20.6% | ||
| —— | —— | —— | —— | ||
| $759.7M-22.6% | $981.16M+95.5% | $501.8M-30.0% | $717M+99.7% | ||
| $17.34M+125% | $7.71M-3.6% | $8M-17.5% | $9.69M+34.8% | ||
| $75.98M+1.1% | $75.16M-4.8% | $78.99M-4.5% | $82.74M+13.1% | ||
| $335.05M+131% | $145.06M+258% | $40.53M-13.2% | $46.71M-69.3% | ||
| $75.98M+1.1% | $75.16M-4.8% | $78.99M-4.5% | $82.74M+13.1% | ||
| $17.34M+125% | $7.71M-3.6% | $8M-17.5% | $9.69M+34.8% | ||
| $75.98M+1.1% | $75.16M-4.8% | $78.99M-4.5% | $82.74M+13.1% | ||
| $17.34M+125% | $7.71M-3.6% | $8M-17.5% | $9.69M+34.8% | ||
| $83.28M+50.5% | $55.32M+29.7% | $42.64M-3.3% | $44.1M+28.3% | ||
| $83.28M+50.5% | $55.32M+29.7% | $42.64M-3.3% | $44.1M+28.3% | ||
| $1.61M-96.9% | $52.37M— | $0— | —— | ||
| $31.1M+175% | $11.3M— | $0— | —— | ||
| $3.83M-60.9% | $9.81M-7.1% | $10.56M+840% | $1.12M-27.1% | ||
| $31.1M+175% | $11.3M— | $0— | —— | ||
| $414.65M+75.3% | $236.51M+13.7% | $207.93M+0.7% | $206.49M+17.5% | ||
| $2.83B+10.2% | $2.56B+48.6% | $1.73B+16.5% | $1.48B+2.0% | ||
| $123K+4.2% | $118K+15.7% | $102K+8.5% | $94K+11.9% | ||
| $0— | $0— | $0— | $0— | ||
| $869.6M+57.4% | $552.37M— | —— | —— | ||
| $520.56M+12.6% | $462.19M+21.6% | $379.98M+26.4% | $300.5M+67.8% | ||
| $137.2M+0.1% | $137M— | $0— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cytokinetics's total assets?
- Cytokinetics (CYTK) holds $1.3B in total assets, up 0.8% year over year.
- How much debt does Cytokinetics have?
- Cytokinetics carries $418.2M in total debt against -$826.6M of shareholders' equity, a debt-to-equity ratio of 2.21.
- How much cash does Cytokinetics have?
- Cytokinetics holds $129.8M in cash and equivalents.
- Can Cytokinetics cover its short-term obligations?
- Its current ratio is 4.21 — current assets exceed current liabilities.
- Where does Cytokinetics's balance sheet data come from?
- Every line is extracted from Cytokinetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
